PMC Articles for PubChem Substance (Select 223366200) - PMC

Links from PubChem Substance

Items: 1 to 20 of 45

<< First< Prev

Page of 3

Next >Last >>

Select item 39559821.

BARRIERS TO HEPATITIS C TREATMENT

Christopher E. McGowan, Michael W. Fried

Liver Int. Author manuscript; available in PMC 2014 Mar 17.

Published in final edited form as: Liver Int. 2012 Feb; 32(0 1): 151–156. doi: 10.1111/j.1478-3231.2011.02706.x

PMCID:: PMC3955982

Abstract Article PDF–173K

Select item 38090772.

Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection

Kenneth E. Sherman, Steven L. Flamm, Nezam H. Afdhal, David R. Nelson, Mark S. Sulkowski, Gregory T. Everson, Michael W. Fried, Michael Adler, Hendrik W. Reesink, Marie Martin, Abdul J. Sankoh, Nathalie Adda, Robert S. Kauffman, Shelley George, Christopher I. Wright, Fred Poordad

N Engl J Med. Author manuscript; available in PMC 2013 Oct 28.

Published in final edited form as: N Engl J Med. 2011 Sep 15; 365(11): 10.1056/NEJMoa1014463. doi: 10.1056/NEJMoa1014463

Correction in:: volume 365 on page 1551

PMCID:: PMC3809077

Abstract Article PDF–209K

Select item 36839923.

Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus

A. Sidney Barritt, IV, Michael W. Fried

Gastroenterology. Author manuscript; available in PMC 2013 Jun 17.

Published in final edited form as: Gastroenterology. 2012 May; 142(6): 1314–1323.e1. doi: 10.1053/j.gastro.2012.02.013

PMCID:: PMC3683992

Abstract Article PDF–1.0M

Select item 36379824.

Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals

Susanna Naggie, Mark S. Sulkowski

Gastroenterology. Author manuscript; available in PMC 2013 May 1.

Published in final edited form as: Gastroenterology. 2012 May; 142(6): 1324–1334.e3. doi: 10.1053/j.gastro.2012.02.012

PMCID:: PMC3637982

Abstract Article PDF–1.6M

Select item 35860685.

Telaprevir

Drugs R D. 2010 Sep; 10(3): 179–202. Published online 2012 Nov 27. doi: 10.2165/11586020-000000000-00000

PMCID:: PMC3586068

Article PDF–240K

Select item 35845726.

Hepatitis C Viral Kinetics The Past, Present, and Future

Anushree Chatterjee, Patrick F. Smith, Alan S. Perelson

Clin Liver Dis. Author manuscript; available in PMC 2014 Feb 1.

Published in final edited form as: Clin Liver Dis. 2013 Feb; 17(1): 13–26. doi: 10.1016/j.cld.2012.09.003

PMCID:: PMC3584572

Article PDF–2.0M

Select item 35845157.

Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hepatitis C virus genotype 1b infection

I Yamada, F Suzuki, N Kamiya, K Aoki, Y Sakurai, M Kano, H Matsui, H Kumada

J Viral Hepat. 2012 Feb; 19(2): e112–e119. doi: 10.1111/j.1365-2893.2011.01514.x

PMCID:: PMC3584515

Abstract Article PDF–160K

Select item 35655928.

Current Management of Hepatitis C Virus Infection in Patients With HIV Co-infection

Mark S. Sulkowski

J Infect Dis. 2013 Mar 15; 207(Suppl 1): S26–S32. doi: 10.1093/infdis/jis764

PMCID:: PMC3565592

Abstract Article PDF–120K

Select item 34994399.

Compensatory substitutions in the HCV NS3/4A protease cleavage sites are not observed in patients treated unsuccessfully with telaprevir combination treatment

James C Sullivan, Eileen Z Zhang, Doug J Bartels, Ann Tigges, Jennifer L Dorrian, Ann D Kwong, Tara L Kieffer

Virol J. 2012; 9: 147. Published online 2012 Aug 6. doi: 10.1186/1743-422X-9-147

PMCID:: PMC3499439

Abstract Article PDF–365K

Select item 348905610.

Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C

N Hayashi, T Okanoue, H Tsubouchi, J Toyota, K Chayama, H Kumada

J Viral Hepat. 2012 Feb; 19(2): e134–e142. doi: 10.1111/j.1365-2893.2011.01528.x

PMCID:: PMC3489056

Abstract Article PDF–231K

Select item 347706811.

New virologic tools for management of chronic hepatitis B and C

Stéphane Chevaliez, Christophe Rodriguez, Jean-Michel Pawlotsky

Gastroenterology. Author manuscript; available in PMC 2012 Oct 22.

Published in final edited form as: Gastroenterology. 2012 May; 142(6): 1303–1313.e1. doi: 10.1053/j.gastro.2012.02.027

PMCID:: PMC3477068

Abstract Article

Select item 340716812.

Evaluation of Persistence of Resistant Variants with Ultra-Deep Pyrosequencing in Chronic Hepatitis C Patients Treated with Telaprevir

Xiomara V. Thomas, Joep de Bruijne, James C. Sullivan, Tara L. Kieffer, Cynthia K. Y. Ho, Sjoerd P. Rebers, Michel de Vries, Hendrik W. Reesink, Christine J. Weegink, Richard Molenkamp, Janke Schinkel

PLoS One. 2012; 7(7): e41191. Published online 2012 Jul 27. doi: 10.1371/journal.pone.0041191

PMCID:: PMC3407168

Abstract Article PDF–373K

Select item 340608713.

The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors

Keith P. Romano, Akbar Ali, Cihan Aydin, Djade Soumana, Ayşegül Özen, Laura M. Deveau, Casey Silver, Hong Cao, Alicia Newton, Christos J. Petropoulos, Wei Huang, Celia A. Schiffer

PLoS Pathog. 2012 Jul; 8(7): e1002832. Published online 2012 Jul 26. doi: 10.1371/journal.ppat.1002832

PMCID:: PMC3406087

Abstract Article PDF–1.1M

Select item 340469514.

Provisional Guidance on the Use of Hepatitis C Virus Protease Inhibitors for Treatment of Hepatitis C in HIV-Infected Persons

David L. Thomas, John G. Bartlett, Marion G. Peters, Kenneth E. Sherman, Mark S. Sulkowski, Paul A. Pham

Clin Infect Dis. 2012 Apr 1; 54(7): 979–983. Published online 2011 Dec 14. doi: 10.1093/cid/cir882

PMCID:: PMC3404695

Abstract Article PDF–218K

Select item 340026715.

Modeling quasispecies and drug resistance in hepatitis C patients treated with a protease inhibitor

Libin Rong, Ruy M. Ribeiro, Alan S. Perelson

Bull Math Biol. Author manuscript; available in PMC 2013 Aug 1.

Published in final edited form as: Bull Math Biol. 2012 Aug; 74(8): 1789–1817. Published online 2012 May 26. doi: 10.1007/s11538-012-9736-y

PMCID:: PMC3400267

Abstract Article PDF–2.0M

Select item 339344516.

Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir

Fiona McPhee, Jacques Friborg, Steven Levine, Chaoqun Chen, Paul Falk, Fei Yu, Dennis Hernandez, Min S. Lee, Susan Chaniewski, Amy K. Sheaffer, Claudio Pasquinelli

Antimicrob Agents Chemother. 2012 Jul; 56(7): 3670–3681. doi: 10.1128/AAC.00308-12